baber/WOPTO huggingface dataset:
Patent JP-2002516648-A (JP)
Title: モジュラースイッチ
IPC: H01H23/14
Filed: 1999-07-16
Abstract: (57)【要約】
使用者が作動させるモジュラースイッチアセンブリー（１０）が、ハウジング（２０）上で第１の位置と第２の位置との間を摺動可能な作動アセンブリー（１２）を有する。シャフトノブ（４０）又は揺動ノブ（３０）が、スイッチの基本的な摺動作動又は揺動作動のどちらかを提供するために、作動アセンブリー（１２）に選択的に取付けられる。作動アセンブリー（１２）は、どちらのタイプのノブの直接の取付も可能にする一体の取付部材を有する。
Patent MX-151670-A (MX)
Inventor: PARKINSON RICHARD G
IPC: E03C1/08
Filed: 1981-03-16
Abstract: This disclosure relates to a flow control device in which the discharge from the nozzle is kept at essentially the same volume rate of flow in spite of fluctuations in the hydraulic pressure upstream from the device by providing a spray body that has a group of radially disposed channels which are perpendicular to the general direction of flow. A flexible spray control washer spaced upstream from these channels responds to hydraulic pressure by pressing into the channels and restricting the flow area of each of these channels in proportion to the applied hydraulic pressure. In this way, the flow area within the chamber is inversely related to the hydraulic pressure in order to maintain a continuous volume rate of flow through the device.
Patent MX-151153-A (MX)
Inventor: DAVIS WALTER LEE
IPC: H04B5/04
Filed: 1981-09-23
Abstract: An battery powered, adaptive signal decoder is disclosed which is capable of processing detected encoded signals in accordance with a plurality of decoding schemes. The decoder has an equivalent microcomputer implementation. Energy conservation means operating independently of the detected signals acts to conserve the energy of the battery.
Patent MX-161909-A (MX)
Inventor: KUXDORF BERNHARD
IPC: C01B25/12
Filed: 1984-04-27
Abstract: The disclosure relates to a process for making phosphorus pentoxide by subjecting elemental yellow phosphorus to combustion with dried air inside a steel-made combustion chamber with utilization of the reaction heat for the production of energy. To this end, the disclosure provides for the combustion to be effected inside a combustion chamber of which the walls are arranged so as to form a cooling system with cavities therein; for a liquid or liquid/steam-mixture as a heat carrier abstracting the reaction heat to be circulated through the cooling system, the liquid or liquid/steam-mixture assuming an increased temperature being preferably so circulated under increased pressure; for steam formed in the cooling system to be continuously taken therefrom; for an equivalent proportion of fresh liquid to be introduced into the cooling system; for hot P2O5 issuing in vapor form from the combustion chamber to be condensed or worked up into desirable final product, the combustion chamber being a cylindrical vessel with a height/diameter-ratio of 2.5:1 to 5:1 and having 1 to 10 burners disposed axisymmetrically in its circular base plate. The disclosure also relates to an apparatus for carrying out the process.
Patent NZ-206836-A (NZ)
Title: Pcm tdm conference bridge
Inventor: ALLAN P
IPC: H04Q11/04
Filed: 1984-01-13
Abstract: A conference bridge for a digital time division multiplex pulse code modulation telecommunication exchange in which for simplicity of operation each conference is allocated a unique channel number and each party within a conference is allocated a unique party number thus allowing any party to join any conference at any time.
Patent NZ-210002-A (NZ)
Title: Conveyor distributes oriented slivers longitudinally on further conveyor to reduce sliver stacking
Inventor: CHURCHLAND M T
IPC: B27N3/14
Filed: 1984-10-26
Abstract: A process and apparatus for continuously forming a product having elongate members (10) at least about one foot long which are oriented, compressed and bonded. The process comprises depositing elongate members (10) on a moving carrier (39) with an orientation that is substantially parallel to the direction of movement of said carrier (39), said members (14) being deposited on said carrier (39) over a length of carrier (39) that is at least as long as about one-half times the length of the elongate members (10) and is at least as long as about 30 times the final thickness of the compressed, composite product. The apparatus comprises a first conveyor (30) along which elongate members (10) travel, said elongate members (10) being arranged transverse to the direction of travel of said first conveyor (30). This first conveyor (30) feeds a second conveyor (33) which is arranged to move transversely of said first conveyor (30) and to collect said elongate members (10). The second conveyor (33) then feeds a third conveyor (39) whereupon the final product is formed.
Patent NZ-212954-A (NZ)
Title: Package for coil of wire:reel within cardboard box
Inventor: DITCHFIELD N J
IPC: B65D85/04
Filed: 1985-08-01
Abstract: An improved coil package comprises a closable carton 21 formed from a folded blank of cardboard and having a pair of oppositely disposed major side walls 22, each of which has an aperture 23 in axial aligment with the aperture of the other major side wall and, removably housed in the carton, a reel on which is carried a coil of wire (not shown). The flanges 34 of the reel have apertures 37 of diameters less than the apertures 23 in the major side walls 22 of the carton and end parts 40 of a rigid hollow hub 39 formed of a transversely folded metal strip protrude from the reel flanges and are so rolled radially outwardly that their extreme edges bite into the outer faces of the reel flanges, no portions of the rolled over end parts of the hub protruding beyond the planes containing the outer faces of the major side walls.
Patent NZ-217314-A (NZ)
Title: Method of stablizing staphylococcus aureus - antibody complex diagnosis and kits
Inventor: ISIED S S
IPC: G01N33/00
Filed: 1986-08-21
Abstract: A method of binding an antibody with protein A cells is provided which includes a sequence of incubation and dilution steps to produce a preselected amount and concentration of antibody with a preselected distribution of antibody among the protein A cells. In addition, a method is provided for preparing an antibody entrapped porous matrix and apparatus which includes a specific porous matrix with a preselected position of antibody bound bacterium cells therein along with means for drawing fluids through the porous medium and means for facilitating the deposition of fluids onto the surface of the porous matrix. The apparatus and method is useful for testing for the level of progesterone in animal body fluids, such as milk, plasma, serum, whole blood and saliva.
Patent NZ-222209-A (NZ)
Title: Personal skin care composition containing dimethyl diallyl ammonium chloride/acrylic acid-type polymers
Inventor: BOOTHE JERRY E
IPC: A61K8/81
Filed: 1987-10-19
Abstract: This invention relates to improved personal skin care products which contain dimethyl diallyl ammonium chloride/acrylic acid-type polymers. These polymers provide exceptional f to skin when personal skin care products containing them, such as hand and face lotions, soaps or creams, suntan lotions, bubble baths, shaving creams, antiperspirants, and deodorants, are used.
Patent NZ-226082-A (NZ)
Title: Process for producing recombinant human factor viii:c and transformants
Inventor: TAKASHI SUGIYAMA
IPC: C12P21/00
Filed: 1988-09-08
Abstract: A transformant of animal cells , preferably CHO cells,is described which is produced by transforming animal cells with an expression vector containing a gene encoding natural type active human Factor VIII:C and upstream thereof at least one promoter and optionally containing further at least one enhancer. One of the transformants of CHO cells contains an expression vector containing a gene encoding 740 Arg-1649 Glu Factor VIII:C . Furthermore a method for producing recombinant human Factor VIII:C , preferably 740 Arg-1649 Glu Factor VIII:C, is described which comprises cultivating the transformant in a medium, preferably in the presence of von Willebrand factor , albumin, polyethylene glycol, sodium selenite,  epsilon -aminocaproic acid, PMSF, aprotinin or cyclodextrins, and recovering the recombinant natural type active human Factor VIII:C accumulated in the culture medium.
Patent NZ-228805-A (NZ)
Title: Synethesis of n-t-alkyl-1,2-diacylhydrazines and insecticidal compositions thereof
Inventor: KELLY MARTHA JEAN
IPC: C07C241/02
Filed: 1989-04-19
Abstract: A process for preparing a N-t-alkyl-1,2-diacylhydrazine comprises reacting a 1, 3, 4-oxadiazole with a tertiary alkyl cation precursor in the presence of a strong acid catalyst.
Patent NZ-230012-A (NZ)
Title: Lightsafe masking film with peelable, reusable lightsafe layer
Inventor: HIROSHI MARUYAMA
IPC: G03F1/00
Filed: 1989-07-20
Abstract: A lightsafe masking film is disclosed which comprises a substrate, a pressure sensitive adhesive layer formed on the substrate, and a lightsafe, peelable layer formed on the adhesive layer and including a dialkyl phthalate, nitrocellulose, a lightsafe colorant and, optionally, a filler and a nitrile rubber. The peelable layer further suitably contains a dialkyl ester of an aliphatic dicarboxylic acid.
Patent NZ-234216-A (NZ)
Title: Vitamin d analogues, preparation and pharmaceutical compositions thereof
Inventor: CALVERLEY MARTIN JOHN
IPC: A61P29/00
Filed: 1990-06-25
Abstract: The present invention relates to compounds of formula (I), in which formula, n is 0 or 1, m is 0 or an integer from 1-7, R<1> and R<2> (which may be the same or different) stand for hydrogen or C1-C8-hydrocarbyl, or, taken together with the carbon bearing the hydroxyl group (starred in formula I), R<1> and R<2> can form a saturated or unsaturated C3-C8 carbocyclic ring. In addition, R<1> and/or R<2> and/or one of the m carbons designatedby the " DEG " may be optionally substituted with a hydroxyl group or one or more chlorine or fluorine atom(s); and finally one of the carbons designated " DEG " may optionally be substituted by one or two C1-C2 alkyl group(s); and derivatives of the compounds of formula I in which one or more hydroxy have been transformed into -O-acyl or -O-glycosyl or phosphate ester groups; such masked groups being hydrolyzable in vivo. The present compounds find use in both the human and veterinary practice in the treatment and prophylaxis of autoimmune diseases (including diabetes mellitus), hypertension, acne, alopecia, skin ageing, imbalance in the imune system, inflammatory diseases such as rheumatoid arthritis and asthma as well as diseases characterized by abnormal cell differentiation and/or cell proliferation, such as e.g. psoriasis and cancer.
Patent NZ-244196-A (NZ)
Title: Transfer belt for papermaking machine; paper side has variable roughness depending on nip pressure
Inventor: EKLUND NILS OLA
IPC: D21F7/08
Filed: 1992-09-03
Abstract: A transfer belt (60) for carrying a paper sheet (40) in a papermachine from a press nip in a closed draw to a transfer point, where it is readily released. The belt comprises a supporting base (62) with a particle-filled polymer coating (80) on its paper-facing surface (66), which surface has a pressure-responsive recoverable degree of roughness. During compression in the nip, the surface (66) becomes relatively smooth to allow a thin, almost continuous water film (100) to form between the belt (60) and the sheet (40), which film holds the sheet to the transfer belt as it leaves the nip. Shortly after leaving the nip, the belt surface recovers its uncompressed roughness, breaking up the water film so as to facilitate the release of the sheet from the belt as it reaches the transfer point. <IMAGE>
Patent NZ-261472-A (NZ)
Title: Patch cord with visible indicator for tracing signal
Inventor: EMMONS DAVID J
IPC: G02B6/42
Filed: 1994-01-07
Abstract: A patch cord includes a cable having a primary transmission member contained within a protective sheathing. An energy transmission member is carried on the cable and extends from a first end to a second end. First and second couplings are connected to the first and second ends of the energy transmission member. The first coupling receives energy from an external source and transmits the energy along the energy transmission member toward the second coupling. The second coupling receives energy from the energy transmission member and generates a visible signal in response to the received energy.
Patent NZ-270760-A (NZ)
Title: 6-aminoalkyl-2-oxobenzo- thiazole and oxazole derivatives; pharmaceutical compositions and intermediates thereof
Inventor: MOUITHYS-MICKALAD ANGE
IPC: A61K31/423
Filed: 1995-03-21
Abstract: 6-Aminoalkyl-benzoxazolinone or -benzothiazolinone derivs. of formula (I) and their salts are new: R1 = H or alkyl; n = 1 or 2; X = O or S; R2 = H or alkyl; R3 = (CH2)mR4; m = 1 - 4; R4 = cycloalkylamino, dicycloalkylamino, N-cycloalkyl-N-alkylamino or a heterocyclic gp. of formula (i) opt. substd. by aryl or aralkyl: s = 4 - 8; or NR2R3 is a gp. of formula (i) substd. by aryl or aralkyl; where aryl is phenyl or naphthyl opt. substd. by halo, alkyl, OH, alkoxy and/or CF3; aralkyl is phenylalkyl or naphthylalkyl opt. substd. by halogen, alkyl, OH, alkoxy and/or CF3; alkyl is 1-6C alkyl; alkoxy is 1-6C alkoxy; and cycloalkyl is 3-9C cycloalkyl.
Patent NZ-328124-A (NZ)
Title: Use of rapamycin to treat immunoflammatory skin or bowel disease
Inventor: CAUFIELD CRAIG EUGENE
IPC: A61K38/13
Filed: 1992-09-15
Abstract: apamycin is said to be useful in treating immunoinflammatory skin and bowel disease in non-human mammals.  Cyclosporin A may be used in conjunction with the rapamycin.  Divisional filed as 501371
Patent NZ-331228-A (NZ)
Title: Holder, for a container, comprising gripping means and one or more bands and a lid
Inventor: GRAY KAY MARIE
IPC: A61J1/16
Filed: 1998-08-04
Abstract: Holder 1 consists of handle 2, body 3 having bands 5 and 6, and lid 6.  Typically it is used for holding a denture plate container.  Optionally notches 11 are provided for drainage.
Patent NZ-331868-A (NZ)
Title: Monoclonal antibodies binding human growth hormone (hGH) with a MW of 20kDa
Inventor: HANSSON YNGVE ELOF
IPC: C12P21/08
Filed: 1997-03-27
Abstract: isclosed is a monoclonal antibody capable of specific binding to the molecular weight of 20 kDa variant of human growth hormone. This monoclonal antibody has no substantial binding to hGH of molecular weight 22 kDa. Also described is the use of this monoclonal antibody for measurement of hGH 20K, especially in body fluids. The antibodies can be used for detection and quantification of hGH 20K, especially in serum.
Patent NZ-333645-A (NZ)
Title: 5-phenoxyalkyl 2,4-thiazolidine diketone derivatives
Inventor: MOINET GERARD
IPC: C07D277/36
Filed: 1997-06-02
Abstract: The 5-phenoxyalkyl 2,4-thiazolidine diketone have the formula (I): wherein: A is an optionally saturated optionally substituted alkylene group; D is a monocyclic, bicyclic or tricyclic, aryl or heteroaryl ring structure; X is a substituent of D and is as defined in the specification; n is 1 to 3; provided when A is butyl radical, then D-(X)n does not represent 4-chlorophenyl group or a tautomer, enantiomer, diastereoisomer, epimer  or salt thereof. A pharmaceutical composition thereof is useful as an anti-diabetic agent and for treating insulin resistance metabolic syndrome.
Patent NZ-334117-A (NZ)
Title: Controlling the ripening of coffee plants with ACC synthase and ACC oxidase DNA sequences
Inventor: STILES JOHN I
IPC: C12N15/11
Filed: 1997-08-11
Abstract: 1-aminocyclopropane-1-carboxylic acid (ACC) oxidase and ACC synthase proteins from the plant Coffea arabica can be used in the control for coffee plant ripening. The ACC oxidase and synthase enzymes catalyse steps in the ethylene biosynthesis pathway. By inhibiting these enzymes the production of ethylene is prevented and the coffee beans do not fully ripen. The coffee plants are transformed with DNA sequences derived from ACC synthase and oxidase. The resulting anti-sense mRNA binds to ACC synthase and oxidase mRNA thereby inactivating it. The DNA sequences can also be used to block ACC synthase and oxidase synthesis by co-suppression. Simultaneous ripening of the coffee beans can be achieved with the application of ethylene.
Patent NZ-334189-A (NZ)
Title: Method for producing water dispersible sterol formulations
Inventor: BURRUANO BRID
IPC: A23L35/00
Filed: 1999-02-15
Abstract: A method for preparing  beta -sitosterol, oryzanol, esters of both of these compounds and related compounds are disclosed which provides the sterol in a readily consumable form. The method includes the spray drying of the  beta -sitosterol in a mixed micelle formulation. The product is provided in a convenient form that can be provided to food or drinks or incorporated into solid and suspension dosage forms.
Patent NZ-335924-A (NZ)
Title: Flat transdermal medicated self-adhesive patch having a temporary peel off foil that extends over the patch and has two recesses with a break line extending from the recesses
Inventor: KIBELE RALF
IPC: A61L15/44
Filed: 1997-12-04
Abstract: A flat self-adhering drug patch comprising a cover foil and a self-adhesive layer containing at least one active agent is disclosed.  The patch additionally comprises a removable carrier material which extends beyond the patch with the cover foil and self-adhesive layer to form a border.  The border is provided with two recesses spaced apart from one another.  A break line is formed in the carrier material and each end point of the break line extends from the recesses.
Patent NZ-337739-A (NZ)
Title: Embankment groomer and/or shaper with articulated arm  attachable to vehicle
Inventor: STEEDMAN GARRY ROGER
IPC: E01H5/04
Filed: 1999-09-09
Abstract: A device particularly suitable for grooming/shaping various snow terrain features used by recreational snowboarders and/or skiers and includes an adjustable arm assembly (2) attachable at one end to a suitable vehicle and being capable of deployment substantially orthogonally to the direction of movement of said vehicle; said arm being substantially elongated and including two or more articulately connected sections (5, 6, 7) and one or more actuator means (11, 12, 13) capable of changing the orientation at least two of said sections (5, 6, 7) with respect to each other. The invention is also suitable as a means of shaping embankments or features of earth, soil, sand and so forth or for cutting grass or similar undergrowth.
Patent NZ-337801-A (NZ)
Title: Calcium phosphopeptide complexes stabilised by phosphopeptides prevent diseases associated with calcium deficiencies
Inventor: REYNOLDS ERIC C
IPC: A61K38/16
Filed: 1998-03-13
Abstract: Phosphopeptides containing the Ser(P) cluster sequence motif Ser(P)-Ser(P)-Ser(P)-Glu-Glu- can stabilise their own weight in amorphous calcium phosphate (ACP) [Ca3(PO4)1.87(HPO4)0.2xH2O] and amorphous calcium fluoride phosphate (ACFP) [Ca8(PO4)5 F x H2O]. The amorphous phases stabilised by the phosphopeptides are an excellent delivery vehicle to co-localise Ca, F, and phosphate at the tooth surface in a slow-release amorphous form producing superior anticaries efficacy. These amorphous phases stabilised by the phosphopeptides also have utility as dietary supplements to increase calcium bioavailability and to help prevent diseases associated with calcium deficiencies.
Patent NZ-503425-A (NZ)
Title: An articulating attachment of a seat to a chassis of a wheelchair which provides for enhanced shock absorption, control and stability
Inventor: HUNT JASON D
IPC: A61G5/04
Filed: 1998-09-30
Abstract: A wheelchair includes a rigid upholstered seat removably mounted on a crossbrace-type chassis. The seat includes a generally square-shaped frame having a clevis assembly depending from each of the four corners of the frame. Each one of a first pair of the clevis assemblies disposed at diagonally opposed front and rear corners of the seat frame is formed with aligned generally pear-shaped openings. Each one of a second pair of the clevis assemblies disposed at the other diagonally opposed front and rear corners of the seat frame is formed with aligned generally horizontal elliptical-shaped openings. An inverted generally U-shaped mounting bracket formed with aligned openings is disposed on each end of each one of a pair of chassis sideframes. Each clevis assembly is engageable with a respective one of the U-shaped brackets so that the respective openings of the engaged brackets are aligned. The pear-shaped openings allow vertical articulation of the chassis relative to the seat in certain instances when a bump, depression or other irregularity on a travel surface is encountered by usually one of the wheels of the wheelchair.
Patent NZ-507353-A (NZ)
Title: Silicon implants for administering substances over long intervals
Inventor: BOWDITCH ANDREW PAUL
IPC: A61K9/00
Filed: 1999-04-16
Abstract: The prior art discloses that porous silicon having porosities of 4-55% would result in mineralisation or no resorption thus making it undesirable for delivery of a beneficial substance of long time intervals.  However the current application describes a silicon implant comprising an active substance, having a porosity of 4-55%, and a structure and composition that is capable of delivering the active over an interval of 1-12 mths.
Patent NZ-507975-A (NZ)
Title: Process for reducing the amount of nitrification-inhibiting sulfur compounds in process waste waters
Inventor: ZIMMERMAN CURT
IPC: C02F9/14
Filed: 2000-11-06
Abstract: A process for reducing the amount of nitrification-inhibiting sulfur compounds in reaction solutions obtained by the sulfur-catalysed conversion of alpha,beta-unsaturated carboxylic acids into the corresponding trans or cis isomer, which comprises adding an oxidizing agent in molar deficiency up to a maximum of twice the molar amount, based on the catalyst compound, to the reaction mixture obtained after the termination of isomerisation and then isolating the corresponding trans or cis isomer in a known manner and working it up and supplying the resultant process waste waters to a biological cleanup stage.
Patent NZ-508546-A (NZ)
Title: Synergistically acting herbicidal mixtures
Inventor: VANTIEGHEM HERVE
IPC: A01N43/72
Filed: 1999-06-12
Abstract: A synergistic herbicidal mixture comprising: (A) at least one 3-heterocyclyl-substituted benzoyl derivative of formula (I), for which the variables are defined herein, and (B) a synergistically effective amount of at least one herbicidal compound selected from the group consisting of acetyl-CoA carboxylase inhibitors, acetolactate synthase inhibitors, amide herbicides, auxin herbicides, auxin transport inhibitors, carotenoid biosynthesis inhibitors, enolpyruvylshikimate 3-phosphate synthase inhibitors, glutamine synthetase inhibitors, mitosis inhibitors, protoporphyrinogen IX oxidase inhibitors, photosynthesis inhibitors, growth substances, and cell wall biosynthesis inhibitors.